NDAQ Nasdaq Inc.

Delisting of Securities of EQONEX LIMITED; Scopus BioPharma Inc.; Peak Bio, Inc.; Statera Biopharma, Inc.; Tricida, Inc.; Arbor Rapha Capital Bioholdings Corp. I; Calithera Biosciences, Inc.; Waitr Holdings Inc.; Allied Healthcare Products, Inc.; and Meta

Delisting of Securities of EQONEX LIMITED; Scopus BioPharma Inc.; Peak Bio, Inc.; Statera Biopharma, Inc.; Tricida, Inc.; Arbor Rapha Capital Bioholdings Corp. I; Calithera Biosciences, Inc.; Waitr Holdings Inc.; Allied Healthcare Products, Inc.; and Metacrine, Inc. from The Nasdaq Stock Market

NEW YORK, March 01, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the ordinary shares of EQONEX LIMITED. EQONEX LIMITED ordinary shares were suspended on November 30, 2022, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Scopus BioPharma Inc. Scopus BioPharma Inc. common stock was suspended on December 19, 2022, and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock and warrant of Peak Bio, Inc. Peak Bio, Inc.’s securities were suspended on January 10, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Statera Biopharma, Inc. Statera Biopharma, Inc. common stock was suspended on January 12, 2023, and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Tricida, Inc. Tricida, Inc. common stock was suspended on January 24, 2023, and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the Class A Common Stock, units, and warrants of Arbor Rapha Capital Bioholdings Corp. I. Arbor Rapha Capital Bioholdings Corp. I’s securities were suspended on January 24, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Calithera Biosciences, Inc. Calithera Biosciences, Inc.’s common stock was suspended on February 2, 2023, and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Waitr Holdings Inc. Waitr Holdings Inc.’s common stock was suspended on February 2, 2023, and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Allied Healthcare Products, Inc. Allied Healthcare Products, Inc.’s common stock was suspended on February 3, 2023, and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Metacrine, Inc. Metacrine, Inc.’s common stock was suspended on February 9, 2023, and has not traded on Nasdaq since that time.

Nasdaq will file a Form 25 with the Securities and Exchange Commission to complete the delistings. The delistings become effective ten days after the Form 25 is filed. For news and additional information about the companies, including the basis for the delisting and whether the companies’ securities are trading on another venue, please review the companies’ public filings or contact the company directly.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at  Nasdaq’s rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: .

-NDAQO- 



EN
01/03/2023

Underlying

NDAQNasdaq Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Nasdaq Inc.

 PRESS RELEASE
Free
NDAQ NASDAQ INC.

Delisting of Securities of TLGY Acquisition Corporation; Target Global...

Delisting of Securities of TLGY Acquisition Corporation; Target Global Acquisition I Corp.; Inception Growth Acquisition Limited; Healthcare AI Acquisition Corp.; Globalink Investment Inc.; BurTech Acquisition Corp; Mountain & Co. I Acquisition Corp.; Pearl Holdings Acquisition Corp; Alpha Star Acquisition Corporation; CF Acquisition Corp. VII; Kairous Acquisition Corp. Limited; Finnovate Acquisition Corp.; Exela Technologies, Inc.; Investcorp Europe Acquisition Corp I; Molecular Templates, Inc. NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it w...

7h / 20m 1 EN
 PRESS RELEASE
Free
NDAQ NASDAQ INC.

Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Sto...

Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date April 15, 2025 NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- At the end of the settlement date of April 15, 2025, short interest in 3,143 Nasdaq Global MarketSM securities totaled 13,211,633,004 shares compared with 13,072,444,217 shares in 3,140 Global Market issues reported for the prior settlement date of March 31, 2025. The mid-April short interest represents 1.76 days compared with 2.64 days for the prior reporting period. Short interest in 1,634 securities on The Nasdaq Capital MarketSM t...

April 25, 2025 1 EN
 PRESS RELEASE
Free
NDAQ NASDAQ INC.

Nasdaq Announces 13% Increase in Quarterly Dividend to $0.27 Per Share

Nasdaq Announces 13% Increase in Quarterly Dividend to $0.27 Per Share NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Nasdaq, Inc. (Nasdaq: NDAQ) has declared a regular quarterly dividend of $0.27 per share on the company's outstanding common stock, a 13% increase from the previous quarter. The dividend is payable on June 27, 2025 to shareholders of record at the close of business on June 13, 2025. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to approval by the Board of Directors. About Nasdaq ...

April 24, 2025 1 EN
 PRESS RELEASE
Free
NDAQ NASDAQ INC.

Nasdaq Reports First Quarter 2025 Results; Diversified Business Model ...

Nasdaq Reports First Quarter 2025 Results; Diversified Business Model Driving Broad-Based Revenue Growth NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) today reported financial results for the first quarter of 2025. First quarter 2025 net revenue1 was $1.2 billion, an increase of 11% over the first quarter of 2024, or up 12.5% on an adjusted2 basis. This included Solutions3 revenue growing 9%, or up 11% on an adjusted basis.Annualized Recurring Revenue (ARR)4 of $2.8 billion increased 8% over the first quarter of 2024, or up 9% on an organic basis. Annualized Sa...

April 24, 2025 1 EN
 PRESS RELEASE
Free
NDAQ NASDAQ INC.

Nasdaq and AWS Unlock New Era of Growth for Global Capital Markets wit...

Nasdaq and AWS Unlock New Era of Growth for Global Capital Markets with Next Generation Infrastructure Solutions Nasdaq and AWS announce modernization blueprint to drive the benefits of cloud into local market infrastructures through flexible deployment while maintaining data sovereignty and resilience As part of the modernization blueprint, Nasdaq is introducing a new brand for its complete suite of next generation marketplace technology solutions, Nasdaq Eqlipse, delivering cloud-ready capabilities and data intelligence across the full trade lifecycle Nasdaq’s Nordic markets first to a...

April 24, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch